Table 4 Initial management strategies for endogenous fungal endophthalmitis
Initial treatment | Yeast (%) | Mold (%) | p value |
|---|---|---|---|
Local ocular therapy | 41/51 (80.4%) | 13/16 (81.3%) | 0.940 |
 Tap | 12/51 (23.5%) | 5/16 (31.3%) | 0.536 |
 PPV | 29/51 (56.9%) | 8/16 (50.0%) | 0.630 |
Systemic treatment | 30/51 (58.8%) | 14/16 (87.5%) | 0.035 |
 Oral | 16/51 (31.4%) | 4/16 (25.0%) | 0.627 |
 Intravenous | 14/51 (27.5%) | 10/16 (62.5%) | 0.011 |